HIGH

Zydus Pharmaceuticals Recalls Entecavir Tablets Over Impurity Issues

Zydus Pharmaceuticals recalled 600 bottles of Entecavir Tablets on September 24, 2025. The recall follows a failed impurity specification that poses health risks. Consumers should stop using the product immediately and contact healthcare providers for guidance.

Quick Facts at a Glance

Recall Date
September 24, 2025
Hazard Level
HIGH
Brands
ENTECAVIR, Zydus Pharmaceuticals USA Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: Letter

Product Details

The recalled product is Entecavir Tablets, USP, 1 mg, in 30-count bottles. It was manufactured by Zydus Lifesciences Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. Lot number is E409309 with an expiration date of December 31, 2026.

The Hazard

The recall involves tablets that failed to meet impurity and degradation specifications. The affected tablets may contain an unapproved organic impurity.

Reported Incidents

No specific injuries or adverse events have been reported related to this recall. The FDA classified this recall as Class II, indicating a potential risk of serious health consequences.

What to Do

Stop using the Entecavir Tablets immediately. Contact Zydus Pharmaceuticals (USA) Inc. or your healthcare provider for further instructions and guidance.

Contact Information

Consumers can reach Zydus Pharmaceuticals at 1-800-XYZ-XXXX. For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0002-2026.

Key Facts

  • 600 bottles recalled
  • Lot#: E409309
  • Expiration: 12/31/2026
  • Class II recall
  • Failed impurity specifications

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeEntecavir Tablets
Sold At
Multiple Retailers

Product Details

Model Numbers
Lot#: E409309
Exp 12/31/2026
UPC Codes
68382-920
68382-921
68382-920-06
+9 more
Affected States
ALL
Report Date
October 8, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more